| P50 | author | Ross J. Baldessarini | Q91160298 |
| | Eduard Vieta | Q20090640 |
| | Stefan Leucht | Q28036857 |
| P2093 | author name string | Ayşegül Yildiz | |
| P2860 | cites work | Introduction to Meta-Analysis | Q106417732 |
| | Efficacy of antidepressants in adults | Q24555325 |
| | Antidepressant drug effects and depression severity: a patient-level meta-analysis | Q24598580 |
| | Statistics review 5: Comparison of means | Q24797209 |
| | Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis | Q27860511 |
| | Meta-analysis in clinical trials | Q27860779 |
| | Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis | Q28189245 |
| | Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study | Q28248076 |
| | Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group | Q28375949 |
| | A rating scale for mania: reliability, validity and sensitivity | Q29619299 |
| | Lamotrigine: a review of its use in bipolar disorder | Q34228876 |
| | A diagnostic interview: the schedule for affective disorders and schizophrenia | Q34269355 |
| | Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis | Q34307827 |
| | Valproate in the treatment of acute mania. A placebo-controlled study | Q34613045 |
| | Research diagnostic criteria: rationale and reliability | Q34711463 |
| | Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group | Q34727272 |
| | How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials | Q34733976 |
| | Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen | Q34757926 |
| | STATISTICAL TREATMENT OF THE LAW OF INITIAL VALUES (LIV) IN AUTONOMIC RESEARCH: A REVIEW AND RECOMMENDATION. | Q35409310 |
| | Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials | Q36466463 |
| | Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials | Q36778511 |
| | Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials | Q36936379 |
| | Chronic administration of mood stabilizers upregulates BDNF and bcl-2 expression levels in rat frontal cortex | Q37088689 |
| | A randomized, placebo-controlled, multicenter study of divalproex sodium extended-release in the acute treatment of mania | Q38374723 |
| | Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study. | Q38385608 |
| | A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania. | Q38402146 |
| | Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials | Q42164457 |
| | A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania. | Q42556946 |
| | Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial | Q42625897 |
| | Confidence intervals for the number needed to treat | Q42759158 |
| | A comparison of two fixed doses of aripiprazole with placebo in acutely relapsed, hospitalized patients with bipolar disorder I (manic or mixed) in subpopulations (CN138-007). | Q42930552 |
| | A randomized, placebo- and active-controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder | Q43011129 |
| | Changes in medication practices for hospitalized psychiatric patients: 2009 versus 2004. | Q43145170 |
| | A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states | Q43258938 |
| | Asenapine versus olanzapine in acute mania: a double-blind extension study | Q43260786 |
| | Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group | Q43507067 |
| | Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness | Q43509323 |
| | Olanzapine versus divalproex in the treatment of acute mania | Q44013092 |
| | Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study | Q44159999 |
| | A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder | Q44275529 |
| | Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial | Q44385585 |
| | A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania | Q44565868 |
| | A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania | Q44684784 |
| | A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. | Q44877765 |
| | Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial | Q44915194 |
| | A double-blind comparison of valproate and lithium in the treatment of acute mania | Q44975667 |
| | Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol | Q45168624 |
| | A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder | Q45237779 |
| | Comparative efficacy and safety of oxcarbazepine versus divalproex sodium in the treatment of acute mania: a pilot study | Q46073014 |
| | Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM). | Q46096014 |
| | Olanzapine compared to lithium in mania: a double-blind randomized controlled trial | Q46146139 |
| | Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study | Q46178044 |
| | Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study | Q46202394 |
| | Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial. | Q46377270 |
| | A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode | Q46428905 |
| | Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial | Q46596821 |
| | Risperidone in the treatment of acute mania: double-blind, placebo-controlled study | Q46681460 |
| | Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial | Q46681464 |
| | Quetiapine or haloperidol as monotherapy for bipolar mania--a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial | Q46683979 |
| | Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study | Q46886132 |
| | Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double-blind study | Q46889468 |
| | Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial. | Q48481499 |
| | Verapamil for the treatment of acute mania: a double-blind, placebo-controlled trial. | Q50877463 |
| | Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial. | Q51903227 |
| | A meta-analysis of the use of typical antipsychotic agents in bipolar disorder. | Q52932623 |
| | Increasing rates of placebo response over time in mania studies. | Q53038901 |
| | Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial | Q59210536 |
| | Carbamazepine compared with lithium in the treatment of mania | Q68027502 |
| | Lithium compared to valproic acid and carbamazepine in the treatment of mania: a statistical meta-analysis | Q71703609 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meta-analysis | Q815382 |
| P304 | page(s) | 375-89 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Neuropsychopharmacology | Q2261280 |
| P1476 | title | Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials | |
| P478 | volume | 36 | |